Skip to content
Biobot Analytics logo

Biobot Analytics

Biobot Analytics is a YC Winter 2018 (W18) company. Based in Cambridge, MA, USA. Team of 12.

  • Health Tech
  • Analytics

About Biobot Analytics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Biobot Analytics turns municipal wastewater into a population health intelligence platform, tracking over 50 pathogens and substances, from SARS-CoV-2 and influenza to fentanyl and methamphetamine. Government agencies and pharmaceutical companies use the data to detect outbreaks and drug trends before they surface in clinical or law-enforcement reports, replacing the lag inherent in hospital surveillance and official case counts.

Business model

Customers book access to Biobot's data platform via a demo-to-contract sales process.

Go-to-market

Federal and state/local government agencies are the primary buyers, alongside pharma and life sciences companies; customers engage through a demo booking flow on the website.

From the Y Combinator listing

How Biobot Analytics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Population health analytics powered by wastewater.

Our mission is to transform wastewater infrastructure into public health observatories. Named as one of Fast Company’s most innovative companies in the world in 2021, Biobot Analytics is a wastewater epidemiology company and uses technology developed at MIT to measure biomarkers in sewage to better understand population health in cities. We first launched an opioid product to support government and public health officials in responding to the opioid epidemic, and in 2020 launched a Covid19 product to estimate the scope and trend of the outbreak in communities. We have operated in almost 500 communities across 43 U.S. states, generating Covid19 case estimates for over 13% of the U.S. population. Battling the opioid epidemic and now the Covid19 pandemic is just the beginning - we’re transforming sewage into a data asset and building a public health database. Eventually, Biobot data will be an early warning system for disease outbreaks, a map of nutrition disparities, and more. Please visit our website at www.biobot.io

Facts

Industry
Government / Government
Location
Cambridge, MA, USA
Team size
12
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works